The objectives of this proposal are to elucidate the molecular mechanism that ensures selectivity of arrestin towards phosphorylated photo-activated rhodopsin and to establish the link between the timing of arrestin binding and the kinetics of photoresponse recovery. Using site-directed mutagenesis, amino acid residues in arrestin that directly interact with rhodopsin, as well as amino acids that participate in individual intramolecular regulatory interactions, are to be identified. On the basis of these data, an approximation of the three-dimensional organization of the arrestin molecule is to be defined. In particular, a mutant form of arrestin that appears to be constitutively active has been produced. This mutant arrestin binds with high affinity to photo-activated rhodopsin regardless of the phosphorylation state of the rhodopsin. It is to be expressed in transgenic mouse photoreceptors in an arrestin null background. Physiological analyses of these mice are to be performed to determine whether the rate-limiting step in photoreceptor deactivation following a light flash is inactivation of photoactivated rhodopsin or inactivation of transducin-activated phosphodiesterase. The characterization of the functional consequences of expressing mutant arrestins in vivo is expected to pave the way for future use of such mutants for gene therapy of congenital retinal disorders.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY011500-03
Application #
2888521
Study Section
Visual Sciences C Study Section (VISC)
Project Start
1997-04-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Sun Health Research Institute
Department
Type
DUNS #
City
Sun City
State
AZ
Country
United States
Zip Code
85351
Tso, Shih-Chia; Chen, Qiuyan; Vishnivetskiy, Sergey A et al. (2018) Using two-site binding models to analyze microscale thermophoresis data. Anal Biochem 540-541:64-75
Vishnivetskiy, Sergey A; Sullivan, Lori S; Bowne, Sara J et al. (2018) Molecular Defects of the Disease-Causing Human Arrestin-1 C147F Mutant. Invest Ophthalmol Vis Sci 59:13-20
Gurevich, Vsevolod V; Gurevich, Eugenia V (2018) GPCRs and Signal Transducers: Interaction Stoichiometry. Trends Pharmacol Sci 39:672-684
Cleghorn, Whitney M; Bulus, Nada; Kook, Seunghyi et al. (2018) Non-visual arrestins regulate the focal adhesion formation via small GTPases RhoA and Rac1 independently of GPCRs. Cell Signal 42:259-269
Gurevich, Vsevolod V; Gurevich, Eugenia V; Uversky, Vladimir N (2018) Arrestins: structural disorder creates rich functionality. Protein Cell 9:986-1003
Chen, Qiuyan; Iverson, Tina M; Gurevich, Vsevolod V (2018) Structural Basis of Arrestin-Dependent Signal Transduction. Trends Biochem Sci 43:412-423
Vishnivetskiy, Sergey A; Lee, Regina J; Zhou, X Edward et al. (2017) Functional role of the three conserved cysteines in the N domain of visual arrestin-1. J Biol Chem 292:12496-12502
Sullivan, Lori S; Bowne, Sara J; Koboldt, Daniel C et al. (2017) A Novel Dominant Mutation in SAG, the Arrestin-1 Gene, Is a Common Cause of Retinitis Pigmentosa in Hispanic Families in the Southwestern United States. Invest Ophthalmol Vis Sci 58:2774-2784
Zhu, Lu; AlmaƧa, Joana; Dadi, Prasanna K et al. (2017) ?-arrestin-2 is an essential regulator of pancreatic ?-cell function under physiological and pathophysiological conditions. Nat Commun 8:14295
Zhou, X Edward; He, Yuanzheng; de Waal, Parker W et al. (2017) Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors. Cell 170:457-469.e13

Showing the most recent 10 out of 144 publications